Period Ending | Oct 2, 2011 | Jul 3, 2011 | Apr 3, 2011 | Dec 31, 2010 |
---|
Total Revenue
|
17,193,000
|
16,984,000
|
16,502,000
|
18,106,000
| Cost of Revenue | 3,679,000 | 3,805,000 | 3,693,000 | 4,603,000 | |
Gross Profit
|
13,514,000
|
13,179,000
|
12,809,000
|
13,503,000
| |
|
Operating Expenses |
|
Research Development | 2,188,000 | 2,237,000 | 2,091,000 | 2,823,000 |
|
Selling General and Administrative | 5,159,000 | 5,386,000 | 5,330,000 | 7,140,000 |
|
Non Recurring | 1,101,000 | 479,000 | 894,000 | 1,175,000 |
|
Others | 1,397,000 | 1,395,000 | 1,376,000 | 1,432,000 |
|
|
|
Total Operating Expenses | 9,845,000 | 9,497,000 | 9,691,000 | 12,570,000 | | |
Operating Income or Loss
|
3,669,000
|
3,682,000
|
3,118,000
|
933,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 3,669,000 | 3,682,000 | 3,118,000 | 933,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 3,669,000 | 3,682,000 | 3,118,000 | 933,000 |
|
Income Tax Expense | 1,235,000 | 1,094,000 | 894,000 | (2,041,000) |
|
Minority Interest | (11,000) | (8,000) | (12,000) | (8,000) |
|
|
|
Net Income From Continuing Ops | 2,434,000 | 2,588,000 | 2,224,000 | 2,974,000 | |
|
Non-recurring Events |
|
Discontinued Operations | 1,315,000 | 30,000 | 10,000 | (76,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
3,738,000
|
2,610,000
|
2,222,000
|
2,890,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
3,738,000
|
2,610,000
|
2,222,000
|
2,890,000
|
|